This is a preview of subscription content, log in via an institution to check access.
Notes
reduced QOL costs were estimated assuming a $40 000 value for a QALY
Reference
Vanderpuye-Orgle J, et al. Evaluating the economic burden of psoriasis in the United States. Journal of the American Academy of Dermatology : 14 Apr 2015. Available from: URL: http://dx.doi.org/10.1016/j.jaad.2015.02.1099
Rights and permissions
About this article
Cite this article
Economic burden of psoriasis in the US significant. PharmacoEcon Outcomes News 727, 12 (2015). https://doi.org/10.1007/s40274-015-2096-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2096-8